Unlock stock picks and a broker-level newsfeed that powers Wall Street.
1.2200
0.0000
(0.00%)
At close: 4:00:01 PM EDT
1.2100
-0.01
(-0.82%)
After hours: 5:57:22 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.69 | -0.71 | -2.89 | 0 |
| Low Estimate | -0.69 | -0.71 | -2.89 | 0 |
| High Estimate | -0.69 | -0.71 | -2.89 | 0 |
| Year Ago EPS | -0.84 | -0.89 | -1.65 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 4 |
| Avg. Estimate | 9.59M | 11.77M | 62.49M | 84.63M |
| Low Estimate | 1.6M | 1.6M | 21.2M | 29.2M |
| High Estimate | 26.55M | 39.1M | 174.34M | 228.51M |
| Year Ago Sales | 9.1M | 10.8M | 149.96M | 62.49M |
| Sales Growth (year/est) | 5.37% | 8.99% | -58.33% | 35.42% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.64 | -0.59 | 0.6 | -0.59 |
| EPS Actual | -0.84 | -0.89 | 0.9 | -0.82 |
| Difference | -0.2 | -0.3 | 0.3 | -0.23 |
| Surprise % | -30.57% | -51.86% | 49.93% | -38.64% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.69 | -0.71 | -2.89 | 0 |
| 7 Days Ago | -0.64 | -0.75 | -2.78 | 0 |
| 30 Days Ago | -0.79 | -0.8 | -2.77 | 0 |
| 60 Days Ago | -0.79 | -0.8 | -2.77 | 0 |
| 90 Days Ago | -0.79 | -0.8 | -2.77 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | 1 | -- |
| Up Last 30 Days | -- | -- | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MGNX | 17.86% | 20.22% | -75.36% | -- |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Neutral to Neutral | 3/25/2025 |
| Downgrade | JMP Securities: Market Outperform to Market Perform | 11/7/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 11/6/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 9/18/2024 |
| Reiterates | HC Wainwright & Co.: Neutral to Neutral | 8/21/2024 |
| Maintains | Citigroup: Buy to Buy | 8/15/2024 |
Related Tickers
CTMX CytomX Therapeutics, Inc.
0.6087
+4.95%
MRSN Mersana Therapeutics, Inc.
0.3399
+1.68%
KPTI Karyopharm Therapeutics Inc.
4.0600
+14.69%
ATRA Atara Biotherapeutics, Inc.
6.13
+2.00%
ZNTL Zentalis Pharmaceuticals, Inc.
1.3550
-2.52%
FATE Fate Therapeutics, Inc.
0.7700
+1.70%
XNCR Xencor, Inc.
9.82
+1.34%
STRO Sutro Biopharma, Inc.
0.6304
+5.90%
ALXO ALX Oncology Holdings Inc.
0.5955
-2.70%
RGNX REGENXBIO Inc.
7.05
+4.29%